杭州赛基生物科技股份有限公司-是一家专注于生命科学研究与临床应用领域，以新型流式细胞免疫平台为重心的高科技公司

首页
language
News Republic
关注我们的最新动态
Predicting Immunotherapy Efficacy with a Single Tube of Blood | Zhao Haitao's Team Latest Review: First Systematic Summary of the Clinical Application Value of PD-1⁺ T Cells in Solid Tumors
Zhao Haitao’s team at PUMCH published a landmark review in *International Immunopharmacology*, systematically summarizing the clinical value of peripheral blood PD-1⁺ T cells as a liquid biopsy biomarker for solid tumors.
3weeks ago
0
0
2278
Literature Review | Methodological Validation and Clinical Value of Cellgenebio Flow Fluorescence Technology in AD Blood Detection
Alzheimer’s blood biomarker detection is advancing clinically, with plasma P-tau217/181 now in major guidelines. Costly equipment limits widespread use, but Cellgenebio’s novel flow fluorescence kit—validated clinically—achieves AUC 0.904 for P-tau181 and >95% accuracy with P-tau181/Aβ42 ratio.
3weeks ago
0
0
2215
CellGene Biotech Flow Cytometry Reagents Used in Published Plasma p-tau217 Alzheimer's Study
A CellGene Biotech flow cytometry-based CBA assay for plasma p-tau217 showed 100% specificity, 88.9% sensitivity, and 92.2% accuracy in distinguishing Alzheimer’s dementia from controls and non-AD dementia, with strong concordance to the ALZpath Simoa assay.
3months ago
0
0
7247
Conference Invitation | Sincerely invite you to participate in the 2023 National Clinical Flow Cytology Testing Conference and the 3rd National Flow Cytology Industry Conference and the 3rd Southern Clinical Flow Forum (Saiji booth number: A8)
The 2023 National Clinical Flow Cytology Testing Conference and the 3rd National Flow Cytology Indus
2years ago
0
0
59056
0571-89167281
marketing@cell-genebio.com
Home
About us
Products
News
User Services
Contact us
|
|
|
|
|
© Copyright 2024 Hangzhou Cellgene Biotechnology Co., Ltd
Friendly link:
Drug Safety Cooperation Alliance
Journal of Drug Epidemiology
National Health Commission
SDA
China Medicinal Biotech Association
China Medicinal Biotech Association
Powerby Feedback Follow Data
Back to Top